Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS)
Three quarters of patients with axSpA reported clinically active disease, with higher proportion of patients with active disease in South Africa and lower proportion in Asia. Our results underline the complexity of the clinical disease activity concept in axSpA and the need for a holistic approach in the patient management, care and treatment.
Authors
- Fernando Andrés Sommerfleck (ORCID: https://orcid.org/0000-0001-6863-7559)
- Denis Poddubnyy (ORCID: https://orcid.org/0000-0002-4537-6015)
- Souzi Makri
- Marco Garrido‐Cumbrera (ORCID: https://orcid.org/0000-0001-9727-1189)
- Shashank Akerkar (ORCID: https://orcid.org/0009-0002-3194-9641)
- Christine Bundy (ORCID: https://orcid.org/0000-0002-5981-3984)
- Victoria Navarro‐Compán (ORCID: https://orcid.org/0000-0002-4527-852X)
- Elie G. Karam (ORCID: https://orcid.org/0000-0002-4681-8225)
- J. Correa-Fernández (ORCID: https://orcid.org/0000-0002-7788-5391)
- Jo Lowe (ORCID: https://orcid.org/0009-0000-5066-3695)
Institutions
- Hospital Universitario La Paz (ES)
- Multiple Sclerosis International Federation (GB)
- University of Cyprus (CY)
- German Rheumatism Research Centre (DE)
- Canadian Standards Association (CA)
- Federación Española de Enfermedades Raras (ES)
- Universidad de Sevilla (ES)
- Cardiff University (GB)
Publication Details
- Journal
- Reumatología Clínica (English Edition)
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1016/j.reumae.2024.11.009
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00